Evidence map›Paper›PMID 37736455›Full record

ArticleCureus2023

Acquired Non-histaminergic Angioedema With C1q Autoantibody and Urticaria: A Case Report.

Andrew P Kochvar, Gavin Cobb, Celina C Bernabe, Terry Levine

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andrew P KochvarCollege of Osteopathic Medicine, Kansas City University, Kansas City, USA.
Gavin CobbCollege of Osteopathic Medicine, Kansas City University, Kansas City, USA.
Celina C BernabeAllergy and Immunology, Allergy & Asthma Care, P.A., Overland Park, USA.
Terry LevineAllergy and Immunology, Allergy & Asthma Care, P.A., Overland Park, USA.
Kansas City University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired angioedema (AAE) is a rare disease with life-threatening complications. This pathology has classically been associated with medication use and B cell lymphoproliferative disorders. In this report, we describe a 61-year-old man with a six-year history of angioedema, unrelated to any known triggers or malignancy. Extensive workup has led to a diagnosis of idiopathic nonhistaminergic AAE with normal C1 inhibitor. The patient is currently being treated with lanadelumab, which has resolved the patient's symptoms. This case provides insight into the onset, exploration, treatment, and outcomes of an extremely rare disease process.

Indexed as

aaeacquired angioedemaanti-c1q antibodyautoimmune diseasebradykininc1q autoantibodyicatibantinh-aaelanadelumaburticaria

Identifiers

PMID37736455
PMCPMC10510307
OpenAlexW4386027752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.